dc.contributor.author |
Ermakova A. |
|
dc.contributor.author |
Morozova J. |
|
dc.contributor.author |
Shalaeva Y. |
|
dc.contributor.author |
Syakaev V. |
|
dc.contributor.author |
Nizameev I. |
|
dc.contributor.author |
Kadirov M. |
|
dc.contributor.author |
Antipin I. |
|
dc.contributor.author |
Konovalov A. |
|
dc.date.accessioned |
2018-04-05T07:09:27Z |
|
dc.date.available |
2018-04-05T07:09:27Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
0959-9436 |
|
dc.identifier.uri |
http://dspace.kpfu.ru/xmlui/handle/net/129746 |
|
dc.description.abstract |
© 2017 The synthesis of small (2–3 nm) silver nanoparticles in the presence of new amidoaminocarboxylic tetrapentylcalix[4]resorcinarene and the binding of the antitumor drug Doxorubicin by a macrocycle in solution and on the surface of nanoparticles are described. |
|
dc.relation.ispartofseries |
Mendeleev Communications |
|
dc.title |
Calixresorcinarene-capped silver nanoparticles as new supramolecular hybrid nanocontainers |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
4 |
|
dc.relation.ispartofseries-volume |
27 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
335 |
|
dc.source.id |
SCOPUS09599436-2017-27-4-SID85026423426 |
|